Loan Loss Reserves / Non-Performing Loans (Annual)

Loan Loss Reserves / Non-Performing Loans: Allowance for bad loans as a portion of total loans made. Calculated as: Loan Loss Reserves / Non-Performing Loans

MEDYTOX SOLUTNS (MMMS) Loan Loss Reserves / Non-Performing Loans data is not available.

Quarterly Annual

Figures for fiscal year ending 2014-12-31

Income Statement Financials
Revenue	57.93M
Net Income	2.81M
Cost of Goods Sold	15.92M
Gross Profit	42.01M
Operating Expenses	42.27M
Operating Income	15.65M
Non-Operating Income/Expense	-0.27M
Pre-Tax Income	15.38M
Normalized Pre-Tax Income	15.38M
Income after Taxes	7.82M
Income from Continuous Operations	7.82M
Consolidated Net Income/Loss	7.82M
Normalized Income after Taxes	7.82M
EBIT	15.65M
EBITDA	17.17M
Weighted-Average Shares Outstanding (Basic)	29.90M
Weighted-Average Shares Outstanding (Diluted)	30.93M
Earnings per Share (EPS) (Basic)	0.09
Earnings per Share (EPS) (Diluted)	0.09
Balance Sheet Financials
Current Assets	20.33M
Property, Plant, and Equipment	7.68M
Long-Term Assets	15.43M
Total Assets	35.76M
Current Liabilities	18.15M
Long-Term Debt	2.32M
Long-Term Liabilities	2.57M
Total Liabilities	20.72M
Common Equity	15.04M
Tangible Shareholders Equity	7.47M
Shareholders Equity	15.04M
Common Shares Outstanding	29.05M
Cash Flow Statement Financials
Cash Flow from Operating Activities	8.25M
Cash Flow from Investing Activities	-4.02M
Cash Flow from Financial Activities	-5.97M
Beginning Cash	4.14M
End Cash	2.41M
Increase/Decrease in Cash	-1.74M
Stock-Based Compensation	0.85M
Common Stock Dividends Paid	--
Preferred Stock Dividends Paid	-5.01M
Fundamental Metrics & Ratios
Current Ratio	1.12
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.13
Debt to Equity Ratio	0.42
Gross Margin	72.52%
Operating Margin	27.02%
EBIT Margin	27.02%
EBITDA Margin	29.64%
Pre-Tax Profit Margin	26.55%
Profit Margin	4.85%
Free Cash Flow	5.76M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	1.62
Inventory Turnover	--
Receiveable Turnover	3.32
Days Sales in Receivables	110.04
Return on Equity	51.98%
Return on Tangible Equity	104.73%
Return on Assets	21.87%
Return on Investments	45.05%
Book Value Per Share	0.52
Free Cash Flow per Share	0.19
Operating Cash Flow per Share	0.27

Data from Zacks Investment Research, Inc.